9-135501094-T-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_016034.5(MRPS2):c.140T>A(p.Leu47His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,606,050 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016034.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPS2 | NM_016034.5 | c.140T>A | p.Leu47His | missense_variant | 2/4 | ENST00000241600.10 | NP_057118.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPS2 | ENST00000241600.10 | c.140T>A | p.Leu47His | missense_variant | 2/4 | 1 | NM_016034.5 | ENSP00000241600 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000281 AC: 64AN: 227936Hom.: 0 AF XY: 0.000254 AC XY: 32AN XY: 125994
GnomAD4 exome AF: 0.000188 AC: 273AN: 1453886Hom.: 1 Cov.: 30 AF XY: 0.000184 AC XY: 133AN XY: 723042
GnomAD4 genome AF: 0.000243 AC: 37AN: 152164Hom.: 0 Cov.: 33 AF XY: 0.000377 AC XY: 28AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | The c.140T>A (p.L47H) alteration is located in exon 2 (coding exon 2) of the MRPS2 gene. This alteration results from a T to A substitution at nucleotide position 140, causing the leucine (L) at amino acid position 47 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
MRPS2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 12, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at